Literature DB >> 29082939

Rifaximin treatment for encephalopathy reduces hospital resource use: real-world data don't fail to IMPRESS.

John D Ryan1, Emmanuel A Tsochatzis1.   

Abstract

Entities:  

Keywords:  encephalopathy

Year:  2017        PMID： 29082939      PMCID： PMC5641850          DOI： 10.1136/flgastro-2017-100852

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN： 2041-4137


× No keyword cloud information.
  3 in total

1.  Rifaximin treatment in hepatic encephalopathy.

Authors:  Nathan M Bass; Kevin D Mullen; Arun Sanyal; Fred Poordad; Guy Neff; Carroll B Leevy; Samuel Sigal; Muhammad Y Sheikh; Kimberly Beavers; Todd Frederick; Lewis Teperman; Donald Hillebrand; Shirley Huang; Kunal Merchant; Audrey Shaw; Enoch Bortey; William P Forbes
Journal:  N Engl J Med       Date:  2010-03-25       Impact factor: 91.245

Review 2.  Liver cirrhosis.

Authors:  Emmanuel A Tsochatzis; Jaime Bosch; Andrew K Burroughs
Journal:  Lancet       Date:  2014-01-28       Impact factor: 79.321

3.  The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-α.

Authors:  James G Orr; Craig J Currie; Ellen Berni; Anurag Goel; Kieran J Moriarty; Ashish Sinha; Fiona Gordon; Anne Dethier; John F Dillon; Katie Clark; Paul Richardson; Paul Middleton; Vishal Patel; Debbie Shawcross; Helen Preedy; Richard J Aspinall; Mark Hudson
Journal:  Liver Int       Date:  2016-04-05       Impact factor: 5.828
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.